Antennova

Executive Summary

Antennova is a private, early-stage biotechnology company founded in 2020 and headquartered in San Francisco, with a focus on developing oncology therapeutics across multiple modalities including antibodies, biologics, and small molecules. The company is led by Dr. Jay Mei, a veteran with over 30 years of experience in clinical research and development of oncology drugs globally, having successfully led multiple approved therapies. This leadership points to strong scientific and strategic direction. As of now, Antennova is in the Phase 1 stage of development, indicating that its most advanced programs have recently entered clinical testing. Detailed information on specific pipeline assets, target indications, or recent trial data is not publicly available, which is typical for a private entity at this stage. The company’s website and available profiles provide limited granularity on its programs, making it challenging to assess the breadth and depth of its pipeline. Nonetheless, the founder’s track record suggests potential for value creation.